首页> 美国卫生研究院文献>Blood >Positive and negative regulation of c-Myb by cyclin D1 cyclin-dependent kinases and p27 Kip1
【2h】

Positive and negative regulation of c-Myb by cyclin D1 cyclin-dependent kinases and p27 Kip1

机译:cyclin D1cyclin依赖性激酶和p27 Kip1对c-Myb的正负调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The c-Myb transcription factor controls differentiation and proliferation in hematopoietic and other cell types and has latent transforming activity, but little is known about its regulation during the cell cycle. Here, c-Myb was identified as part of a protein complex from human T cells containing the cyclin-dependent kinase (CDK) CDK6. Assays using model reporter constructs as well as endogenous target genes showed that the activity of c-Myb was inhibited by cyclin D1 plus CDK4 or CDK6 but stimulated by expression of the CDK inhibitors p16 Ink4a, p21 Cip1, or p27 Kip1. Mapping experiments identified a highly conserved region in c-Myb which, when transferred to the related A-Myb transcription factor, also rendered it responsive to CDKs and p27. The results suggest that c-Myb activity is directly regulated by cyclin D1 and CDKs and imply that c-Myb activity is regulated during the cell cycle in hematopoietic cells.
机译:c-Myb转录因子控制着造血细胞和其他细胞类型的分化和增殖,并具有潜在的转化活性,但对其在细胞周期中的调控了解甚少。在这里,c-Myb被鉴定为来自人类T细胞的蛋白复合物的一部分,该蛋白含有细胞周期蛋白依赖性激酶(CDK)CDK6。使用模型报告基因构建体以及内源性靶基因进行的分析表明,c-Myb的活性受到细胞周期蛋白D1 + CDK4或CDK6的抑制,但受到CDK抑制剂p16 Ink4a,p21 Cip1或p27 Kip1表达的刺激。定位实验确定了c-Myb中一个高度保守的区域,当该区域转移到相关的A-Myb转录因子时,也使其响应CDK和p27。结果表明,c-Myb活性受细胞周期蛋白D1和CDK的直接调控,暗示c-Myb活性在造血细胞的细胞周期中受到调控。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号